Dr. Reddy's Laboratories LimitedRDYNYSE
Loading
EPS Growth Under PressureDecelerating
Percentile Rank26
Year-over-Year Change
Year-over-year earnings per share growth rate
Percentile
P26
Within normal range
vs 3Y Ago
-1.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -15.87% |
| Q3 2025 | 1.35% |
| Q2 2025 | -10.93% |
| Q1 2025 | 12.79% |
| Q4 2024 | 12.62% |
| Q3 2024 | -9.77% |
| Q2 2024 | 6.31% |
| Q1 2024 | -5.19% |
| Q4 2023 | -6.91% |
| Q3 2023 | -78.92% |
| Q2 2023 | 46.49% |
| Q1 2023 | -23.29% |
| Q4 2022 | 11.41% |
| Q3 2022 | -5.81% |
| Q2 2022 | 1255.30% |
| Q1 2022 | -87.60% |
| Q4 2021 | -28.80% |
| Q3 2021 | 73.64% |
| Q2 2021 | 3.18% |
| Q1 2021 | 2705.04% |
| Q4 2020 | -97.41% |
| Q3 2020 | 31.54% |
| Q2 2020 | -24.21% |
| Q1 2020 | 234.13% |
| Q4 2019 | -152.13% |
| Q3 2019 | 64.91% |
| Q2 2019 | 52.60% |
| Q1 2019 | -10.43% |
| Q4 2018 | -3.62% |
| Q3 2018 | 10.44% |
| Q2 2018 | 50.91% |
| Q1 2018 | -9.67% |
| Q4 2017 | 17.35% |
| Q3 2017 | 381.23% |
| Q2 2017 | -81.06% |
| Q1 2017 | -33.58% |
| Q4 2016 | 59.44% |
| Q3 2016 | 138.93% |
| Q2 2016 | 70.48% |
| Q1 2016 | -87.13% |